MALLADI DRUGS AND PHARMACEUTICALS LTD

MALLADI DRUGS AND PHARMACEUTICALS LTD (India) holds 29 active US FDA Type II Drug Master Files and 2 inactive, has DMF or CEP filings on record for 24 active ingredients and is linked to 3 FDA-registered manufacturing sites. 1 FDA enforcement record is linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “MALLADI DRUGS AND PHARMACEUTICALS LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/malladi-drugs-and-pharmaceuticals-ltd

Overview

MALLADI DRUGS AND PHARMACEUTICALS LTD is an active pharmaceutical ingredient (API) supplier with 29 active FDA Type II Drug Master Files, covering (1S,2S)-1-CHLORO-1-PHENYLPROPAN-2-AMINE HYDROCHLORIDE; 2-(4' METHOXYPHENYL) -2-(1-HYDROXYCYCLOHEXYL) ETHYLAMINE ACETATE (MHE ACETATE); 2,4-DICHLOROBENZYL ALCOHOL; 6,7- DIMETHOXY- 3,4- DIHYDROISOQUINOLINE HYDROCHLORIDE; ALPRAZOLAM; AMYLMETACRESOL.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which MALLADI DRUGS AND PHARMACEUTICALS LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

MALLADI DRUGS AND PHARMACEUTICALS LTD holds 29 active (31 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • MINOXIDILActive2026-09-07
  • EPINEPHRINEActive2026-09-07
  • AMYLMETACRESOLActive2026-03-31
  • (1S,2S)-1-CHLORO-1-PHENYLPROPAN-2-AMINE HYDROCHLORIDEActive2026-03-26
  • CHLOROMETHYL-(R)-2-((R)-2-METHOXY-2-OXO-1-PHENYLETHYL)PIPERIDINE-1-CARBOXYLATEActive2026-03-26
  • 2,4-DICHLOROBENZYL ALCOHOLActive2026-02-13
  • HEXYLRESORCINOLActive2025-12-12
  • BILASTINEActive2025-02-28
  • DOXYLAMINE SUCCINATEActive2023-12-26
  • PHENTERMINE HYDROCHLORIDEActive2023-11-08
  • RITALINIC ACIDActive2023-04-27
  • TRANEXAMIC ACIDActive2022-07-29
  • CHLORPHENIRAMINE MALEATEActive2019-08-14
  • EPHEDRINE SULFATEActive2019-01-14
  • D-THREO RITALINIC ACIDActive2018-10-26
  • DOTA [1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID]Active2018-07-20
  • DEXTROMETHORPHAN HYDROBROMIDEActive2018-01-04
  • METARAMINOL TARTRATEActive2017-09-29
  • 6,7- DIMETHOXY- 3,4- DIHYDROISOQUINOLINE HYDROCHLORIDEActive2016-01-07
  • LORAZEPAMActive2009-11-05
  • D THREO RITALINIC ACID HYDROCHLORIDEActive2009-08-07
  • PHENYLEPHRINE BITARTRATEActive2007-04-23
  • ALPRAZOLAMActive2007-04-10
  • 2-(4' METHOXYPHENYL) -2-(1-HYDROXYCYCLOHEXYL) ETHYLAMINE ACETATE (MHE ACETATE)Active2006-08-31
  • THREO-RITALINIC ACID AND SALTActive2006-05-09
  • PHENYLEPHRINE AND SALTActive2005-09-20
  • TRIPROLIDINE HYDROCHLORIDEActive2004-10-14
  • D-PSEUDOEPHEDRINE SULFATEActive2002-09-05
  • D-PSEUDOEPHEDRINE HYDROCHLORIDEActive1993-06-24
  • PSEUDOEPHEDRINE BASEInactive1991-11-01
  • EPHEDRINE HYDROCHLORIDEInactive1990-11-01

Registered manufacturing sites (3)

Physical sites registered with the US FDA and resolved to MALLADI DRUGS AND PHARMACEUTICALS LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

1 FDA enforcement record linked to this company.

  • warning_letter2018-03-09

    FDA Warning Letter (drug product)

For suppliers

Is this MALLADI DRUGS AND PHARMACEUTICALS LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.